- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03902405
Computerized Exercise to Alter Stimulant Approach Responses (CEASAR)
CEASAR (Computerized Exercise to Alter Stimulant Approach Responses) - Piloting a Novel Intervention to Improve Outcomes in Individuals Suffering From Cocaine or Methamphetamine Use Disorder: A Randomized Controlled Study
Study Overview
Status
Intervention / Treatment
Detailed Description
Purpose: To examine a novel computerized exercise intervention as an add-on to currently available evidence-based stimulant use cessation treatments. This study will evaluate whether or not this intervention can improve stimulant use disorder outcomes in a population with concurrent disorders that are difficult to treat.
Hypothesis: 1) The intervention will be easy to integrate in the existing program. 2) Participation in the experimental (stimulant-avoidance) condition will reduce craving (as assessed by the stimulant craving questionnaire brief version), show reduction in an automatic association of activities with stimulant use and stimulant relapses (as assessed by behaviour association questionnaires) and have reduced relapses as assessed by urine drug screens in 12 weeks following initiation of the intervention.
Justification: Stimulant use disorders are among the most challenging disorders, specifically in individuals suffering from concurrent disorders or also identified as dual diagnosis. While medication is available to support the treatment of other substance use disorders (alcohol, opioids, tobacco), currently there is none to treat stimulant use disorders, such as cocaine use disorder and methamphetamine use disorder. Recently, a group in Europe developed the "retraining of automatic approach" intervention, which is based on simple mechanistic retraining for avoidance of substances. This method was successfully applied to change drinking behaviour in a sample of alcoholic inpatients. Participants respond to substance cues by initiating a distancing activity (pushing a joystick away). In contrast, healthy activities are "approached" or pulled in using the joystick. This differential activity trains participants to alter initial responses and "cognitive biases" to simply and automatically avoid substances.
Objectives: Test the hypothesis and evaluate whether or not the Computerized Exercise to Alter Stimulant Approach Responses (CEASAR) can improve stimulant use disorder outcomes in a population with concurrent disorders that are difficult to treat.
Research design: This study is a randomized, single blind, controlled trial involving in-patients with a stimulant use disorder. The participants will be split up equally into 2 groups: the active CEASAR intervention (experimental condition) and the placebo intervention (control). Patients are able to stay at the BCMHA for 6 months with the average being 4-5 months and the study will take place over 12 weeks during their stay. Both groups will use a joystick to push away ("avoid") or pull in ("approach") randomized stimulant and healthy cues presented on a computer screen. In the experimental condition, pushed pictures will exclusively be stimulant use-related pictures, while pulled pictures will be exclusively healthy. In the control condition, stimulant use-related pictures will be equally divided into push and pull conditions. Some of the cues will be visual (e.g. pictures of cocaine powder, pipes, needles etc.) and some of them will be textual (e.g. words like eight ball, rock, etc.).
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anastasia Frank Cheng, MPH
- Phone Number: 604-827-4381
- Email: afrank@cheos.ubc.ca
Study Contact Backup
- Name: Christian Schutz, MD PhD
- Phone Number: 778-873-4785
- Email: christian.schutz@ubc.ca
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5G 3H4
- Recruiting
- Burnaby Centre for Mental Health and Addiction
-
Contact:
- Anastasia Frank Cheng, MPH
- Phone Number: 604-827-4381
- Email: afrank@cheos.ubc.ca
-
Contact:
- Christian Schutz, MD PhD MPH
- Phone Number: 778-873-4785
- Email: christian.schutz@ubc.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- In-patient of the Burnaby Centre of Mental Health & Addiction
- 19 years of age or older
- Individuals with a current stimulant use disorder (cocaine, crack cocaine, amphetamine, methamphetamine, crystal meth), active before intake at BCMHA (as assessed by the MINI)
- Proficiency to read and write English and competent to provide consent
Exclusion Criteria:
- Individuals not stabilized enough to allow for regular participation in the intervention (determined by treating psychiatrist)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Active CEASAR Intervention
Participants will be given the active CEASAR intervention where they will be trained to "avoid" cues associated with stimulant use and approach healthy cues based on the orientation of the images presented.
Individuals will be asked to approach (pull in) portrait images and avoid (push away) landscape images.
In the active condition, pushed pictures (landscape orientation) will exclusively be stimulant-use related pictures.
Conversely, healthy images will be in the portrait orientation which will be pulled in.
|
Healthy and stimulant-use related pictures will be presented on a computer screen.
Using a joystick, participants will be trained to pull in pictures that are presented in portrait orientation, and push those presented horizontally.
In the active experimental condition, pushed pictures will exclusively be stimulant-related pictures.
|
Placebo Comparator: Placebo CEASAR
In the control condition, stimulant use-related pictures will be randomized and equally divided into push (landscape) and pull (portrait) conditions.
|
In the control condition, stimulant cues and healthy cues will be randomized and stimulant use-related pictures will be equally divided into push and pull conditions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in craving as assessed by the Stimulant Craving Questionnaire-Brief (SCQ-B)
Time Frame: Baseline, 4 weeks, 8 weeks, 12 weeks
|
Changes in craving will be assessed at baseline before the intervention, and at 4, 8, and 12 weeks after.
It will be assessed by the Stimulant Craving Questionnaire-Brief (SCQ-B), which uses a 7-item scale (0 = Strongly Disagree, 6 = Strongly Agree) that can produce a composite score between 0 and 6.
On this scale, lower scores indicate less craving which is considered a better outcome.
Higher scores indicate more craving which is considered a worse outcome.
|
Baseline, 4 weeks, 8 weeks, 12 weeks
|
Change in Behavioural association as assessed by the Behaviour Association Scale
Time Frame: Baseline, 4 weeks, 8 weeks, 12 weeks
|
The Behaviour Association Scale measures association of substance use with different situations. Subscale 1, Word Associations: participants list the first word or phrase they associate with a given word. There are 13 word prompts, so the scale runs from 0 (no prompts associated with substance use) to 13 (all prompts associated with substance use). A low score is considered a better outcome because it means fewer situations are associated with substance use. Subscale 2, Behavioral Associations: operates the same way, except that there are 20 prompts listed so the scale runs from 0-20. These subscales are each measured on 2 dimensions, for a total of 4 dimensions to the scale. Dimension A: Each subscale is self-coded by the participant, where the participant determines if their response is substance-use related. Dimension B: Each subscale is researcher-coded, where 2 coders determine whether or not the response is unambiguously related to substance use. |
Baseline, 4 weeks, 8 weeks, 12 weeks
|
Relapse to use as assessed by weekly self-reports and urine drug screens
Time Frame: Between week 2 and week 12
|
Number of relapse days between week 2 and week 12 will be assessed.
|
Between week 2 and week 12
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Christian Schutz, MD PhD MPH, University of British Columbia
Publications and helpful links
General Publications
- Wiers RW, Eberl C, Rinck M, Becker ES, Lindenmeyer J. Retraining automatic action tendencies changes alcoholic patients' approach bias for alcohol and improves treatment outcome. Psychol Sci. 2011 Apr;22(4):490-7. doi: 10.1177/0956797611400615. Epub 2011 Mar 9.
- Wiers RW, Rinck M, Kordts R, Houben K, Strack F. Retraining automatic action-tendencies to approach alcohol in hazardous drinkers. Addiction. 2010 Feb;105(2):279-87. doi: 10.1111/j.1360-0443.2009.02775.x.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H16-01099
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance-Related Disorders
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Substance Use | Substance Use Disorders | Substance Abuse | Substance Dependence | Substance Related Problem
-
Norwegian University of Science and TechnologyCompletedSubstance-related DisordersNorway
-
University of Southern CaliforniaNational Institute on Drug Abuse (NIDA)Completed
-
University Hospital, Basel, SwitzerlandPsychiatric Hospital of the University of BaselCompleted
-
University of LuebeckFederal Ministry of Health, GermanyCompletedSubstance-related Disorders
-
University of Illinois at Urbana-ChampaignCompletedSubstance-related Disorders
-
US Department of Veterans AffairsCompletedAlcoholism | Substance Use Disorders | Substance Abuse | Alcohol Abuse | Substance DependenceUnited States
-
VA Office of Research and DevelopmentRecruiting
-
National Institute on Drug Abuse (NIDA)CompletedSubstance-related Disorders
-
University of NebraskaCompletedSubstance-related Disorders | Alcohol-related DisordersUnited States
Clinical Trials on Active CEASAR Intervention
-
University of South FloridaNational Cancer Institute (NCI)Completed
-
KU LeuvenTerminated
-
Vanderbilt UniversityCompletedObesity | Exercise | Diet | Behavioral ResearchUnited States
-
Duke UniversityAgency for Healthcare Research and Quality (AHRQ)CompletedPhysical Activity | Dietary Habits | Tobacco Use CessationUnited States
-
Limbix Health, Inc.CompletedDepressive Disorder | Depression | Depressive Symptoms | Depressive EpisodeUnited States
-
The Royal Ottawa Mental Health CentreRecruitingSchizophrenia / Schizoaffective Disorder | Depression / Major Depressive DisorderCanada
-
The Royal Ottawa Mental Health CentreCompletedSchizophrenia | Schizoaffective DisorderCanada
-
Universidad Santo TomasUniversidad Pública de NavarraCompletedPhysical Activity | Attention Deficit Hyperactivity Disorder | Child Behavior | BehaviorChile
-
Universiti Putra MalaysiaRecruitingBody Weight Changes | Physical Inactivity | Mental Health IssueChina